source · text/csv
source_cbb6e676153448a1
sha256 7293b49c51c0136072fc78b04bd3f2fbec1730876ff8b410b324b1bdf04fb054
by researka:v2 · 2026-06-06 01:30:39.154916+04:00
study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity The STEP 3 Randomized Clinical Trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity The STEP 4 Randomized Clinical Trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Efficacy and safety of once‐weekly subcutaneous semaglutide on weight loss in patients with overweight or obesity without diabetes mellitus—A systematic review and meta‐analysis of randomized controlled trials,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Patients Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
metadata
{
"researka_object_type": "publication_sidecar",
"researka_publication_id": "9d97b7b1-36f4-4821-bdc9-3b7c90c59e31",
"researka_submission_id": "528df179-e541-46ef-8394-749f1e725472",
"sidecar_name": "evidence_table.csv",
"sidecar_url": "https://api.researka.org/publications/9d97b7b1-36f4-4821-bdc9-3b7c90c59e31/sidecars/evidence_table.csv"
}